ArticleACS omega2025
A Two-Stage Method for Purifying Alpha-Mangostin: Sequential Solvent Extraction and Preparative Liquid Chromatography.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research aimed to establish the optimal conditions for the purification of alpha-mangostin from mangosteen pericarp, employing a two-stage process involving solvent extraction and liquid chromatography. Initially, a sequential solvent extraction protocol, utilizing deionized water and hexane, was implemented to effectively remove both polar and nonpolar impurities. Subsequently, alpha-mangostin was extracted using acetonitrile, and the solvent was removed through evaporation and precipitation, yielding a xanthone-rich fraction. This fraction was then subjected to quantitative liquid chromatography, wherein the influence of mobile phase flow rate, mobile phase composition, feed concentration, and column temperature on purification efficiency was systematically evaluated. The optimized purification parameters, namely a mobile phase flow rate of 4 mL/min, a mobile phase composition of 80% acetonitrile and 20% deionized water, a feed concentration of 3 mg/mL, and a column temperature of 35 °C, resulted in alpha-mangostin with a purity of 83.33%.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.